Dong-yu Gao
Hsinchu, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in mice.
Journal: Journal of drug targeting
Published: December 19, 2017
Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Journal: Theranostics
Published: May 24, 2017
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 05, 2015
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 19, 2015
In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
Journal: Advanced drug delivery reviews
Published: January 03, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026